Sun Pharmaceuticals Industries Ltd (BOM:524715)
â‚ą 1811.35 19.85 (1.11%) Market Cap: 4.34 Tn Enterprise Value: 4.16 Tn PE Ratio: 39.25 PB Ratio: 6.28 GF Score: 95/100

Q1 2022 Sun Pharmaceutical Industries Ltd Earnings Call Transcript

Jul 30, 2021 / 01:00PM GMT
Release Date Price: â‚ą774 (+10.06%)
Operator

Ladies and gentlemen. Good day, and welcome to the Q1 FY '22 Earnings Conference Call of Sun Pharmaceutical Industries Limited. (Operator Instructions) I now hand the conference over to Mr. Nimish Desai, Head of Investor Relations. Thank you, and over to you, Mr. Desai.

Nimish Desai
Sun Pharmaceutical Industries Limited - Head of IR

Thank you. Good evening, and a warm welcome to our first quarter FY '22 earnings call. I'm Nimish from the Sun Pharma Investor Relations team. We hope you received the Q1 financials and the press release that was sent out earlier in the day. These also are available on our website. We have with us Mr. Dilip Shanghvi, Managing Director; Mr. C.S. Muralidharan, CFO; Mr. Abhay Gandhi, CEO of North America; and Mr. Kirti Ganorkar, CEO of India business. Today, the team will discuss performance highlights, update on strategies and respond to any questions that you may have. As is usual, for ease of discussion, we will look at the consolidated financials. Just as a reminder, this call is being recorded and the replay will be available for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot